Troy Wilson E.'s most recent trade in Kura Oncology Inc was a trade of 36,506 Common Stock done at an average price of $5.9 . Disclosure was reported to the exchange on Aug. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.85 per share. | 12 Aug 2025 | 36,506 | 37,474 (0%) | 0% | 5.9 | 213,578 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 6.64 per share. | 12 Aug 2025 | 13,494 | 50,968 (0%) | 0% | 6.6 | 89,623 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 06 Aug 2025 | 22,000 | 69,425 | - | 45 | 990,000 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.03 per share. | 06 Aug 2025 | 22,000 | 91,425 | - | 12.0 | 264,660 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 06 Aug 2025 | 17,777 | 17,776 | - | 45 | 799,965 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 06 Aug 2025 | 17,777 | 17,776 | - | 45 | 799,965 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 06 Aug 2025 | 15,000 | 285,000 | - | 45 | 675,000 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 06 Aug 2025 | 15,000 | 285,000 | - | 45 | 675,000 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 7,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 06 Aug 2025 | 7,500 | 69,425 | - | 45 | 337,500 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.48 per share. | 06 Aug 2025 | 7,500 | 76,925 | - | 12.5 | 93,600 | Common Stock |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 13 Jun 2025 | 10,800 | 43,550 (0%) | 0% | 3.4 | 36,720 | Common Stock |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 27,000 | 54,350 (0%) | 0% | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 10,034 | 10,034 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 6,692 | 69,425 | - | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 625,000 | 625,000 | - | - | Option to purchase common stock | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 27,000 | 27,350 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 3.33 per share. | 13 Jun 2024 | 27,000 | 350 (0%) | 0% | 3.3 | 89,902 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 13,489 | 13,489 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | E. Troy Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.23 per share. | 24 Jan 2024 | 84,107 | 559 (0%) | 0% | 20.2 | 1,701,485 | Common Stock |
| Kura Oncology Inc | E. Troy Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 24 Jan 2024 | 84,107 | 84,666 (0%) | 0% | 6.1 | 517,258 | Common Stock |
| Kura Oncology Inc | Wilson E. Troy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.23 per share. | 24 Jan 2024 | 6,945 | 559 (0%) | 0% | 20.2 | 140,497 | Common Stock |
| Kura Oncology Inc | Wilson E. Troy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 24 Jan 2024 | 6,945 | 7,504 (0%) | 0% | 4.8 | 33,336 | Common Stock |
| Kura Oncology Inc | Wilson Troy E. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 560,000 | 560,000 | - | - | Option to purchase common stock | |
| Avidity Biosciences Inc | Wilson Troy E. | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 300,000 | 263,711 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 300,000 | 300,000 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy Wilson E. | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 250,000 | 13,711 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy Wilson E. | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 250,000 | 300,000 | - | 0 | Common Stock | |
| Kura Oncology Inc | E. Wilson Troy | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Dec 2023 | 2,000 | 559 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy Wilson E. | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Dec 2023 | 1,000 | 279,194 (0%) | 0% | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 27,000 | 27,350 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 3.45 per share. | 13 Jun 2023 | 27,000 | 350 (0%) | 0% | 3.5 | 93,269 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 300,000 | 300,000 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 300,000 | 280,194 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 300,000 | 580,194 (1%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 212,500 | 880,194 (1%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 41,318 | 1,092,694 (2%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 27,966 | 2,559 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 8,394 | 0 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 8,394 | 1,134,012 (2%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 1,084,300 | 1,125,618 (2%) | 2% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 1,084,300 | 8,394 (0%) | 2% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 560,000 | 560,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 468,297 | 1,151,720 (2%) | 1% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 41,318 | 1,092,694 (2%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 41,318 | 41,318 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 17,708 | 1,134,012 (2%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 11,985 | 30,525 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 16 Jun 2022 | 27,858 | 27,350 (0%) | 0% | 2.6 | 71,971 | Common Stock |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 27,000 | 55,208 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 495,000 | 495,000 | - | - | Option to purchase common stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 27,858 | 28,208 (0%) | 0% | 0 | COMMON STOCK | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 100,000 | 100,000 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 100,000 | 89,618 | - | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 11,855 | 90,210 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 01 Dec 2020 | 11,855 | 39,951 (0%) | 0% | 6.1 | 72,908 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 06 Oct 2020 | 106,736 | 0 (0%) | 0% | 34 | 3,629,024 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 06 Oct 2020 | 99,900 | 106,736 (0%) | 0% | 32 | 3,196,800 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 50,370 | 102,065 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 06 Oct 2020 | 50,370 | 28,096 (0%) | 0% | 34 | 1,712,580 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 06 Oct 2020 | 50,370 | 78,466 (0%) | 0% | 6.2 | 309,776 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 4,586 | 152,435 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 06 Oct 2020 | 4,586 | 28,096 (0%) | 0% | 34 | 155,924 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 06 Oct 2020 | 4,586 | 32,682 (0%) | 0% | 6.2 | 28,204 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 06 Oct 2020 | 100 | 206,636 (0%) | 0% | 32 | 3,200 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.82 per share. | 11 Sep 2020 | 98,490 | 206,736 (0%) | 0% | 28.8 | 2,838,876 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 11 Sep 2020 | 17,926 | 46,022 (0%) | 0% | 6.2 | 110,245 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 17,926 | 157,021 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 11 Sep 2020 | 17,926 | 28,096 (0%) | 0% | 28 | 501,928 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 11 Sep 2020 | 485 | 305,226 (0%) | 0% | 28 | 13,580 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 08 Sep 2020 | 50,000 | 306,736 (0%) | 0% | 26 | 1,300,000 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 08 Sep 2020 | 37,030 | 65,126 (0%) | 0% | 6.2 | 227,735 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 08 Sep 2020 | 37,030 | 28,096 (0%) | 0% | 28 | 1,036,840 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2020 | 37,030 | 174,947 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 08 Sep 2020 | 1,025 | 305,711 (0%) | 0% | 28 | 28,700 | Common Stock |